Relationship between body mass index and mortality in hemodialysis patients: A meta-analysis

Nephron - Clinical Practice

Volumn 121, Issue 3-4, 2013, Pages

  Jialin, Wang ^a   Yi, Zhou ^a   Weijie, Yuan ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Body mass index; Hemodialysis; Meta analysis; Mortality; Systematic review

Indexed keywords

ADRENALIN; CYTOKINE; RENIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADRENALIN BLOOD LEVEL; ARTICLE; BODY MASS; BODY SIZE; CACHEXIA; DISEASE ASSOCIATION; FOLLOW UP; HEART PROTECTION; HEMODIALYSIS PATIENT; HEMODYNAMICS; HUMAN; META ANALYSIS; MORBID OBESITY; MORTALITY; MUSCLE MASS; NUTRITIONAL STATUS; OBESITY; OUTCOME ASSESSMENT; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMATIC REVIEW; UNDERWEIGHT; WEIGHT CHANGE; WEIGHT REDUCTION;

BODY MASS INDEX; COMORBIDITY; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; OBESITY; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84869873049     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000345159     Document Type: Article

References (42)

1. Arcan C, Hannan PJ, Himes JH, et al: American Indian parents' assessment of and concern about their kindergarten child's weight status. South Dakota, 2005-2006. Prev Chronic Dis 2012; 9:E56.
2. Wang Y, Chen X, Song Y, et al: Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 2008; 73: 19-33. (Pubitemid 350273639)
3. Johansen KL, Kutner AG, Young B, et al: Association of body size with health status in patients beginning dialysis. Am J Clin Nutr 2006; 83: 543-549. (Pubitemid 44699198)
4. de Mutsert R, Snijder MB, van der Sman-de Beer F, et al: Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of followup. J Am Soc Nephrol 2007; 18: 967-974. (Pubitemid 46434514)
5. Yen TH, Lin JL, Lin-Tan DT, Hsu CW: Association between body mass and mortality in maintenance hemodialysis patients. Ther Apher Dial 2010; 14: 400-408.
6. Physical status: the use and interpretation of anthropometry: report of a WHO Expert Committee. World Health Organization 1995; 854: 1-452.
7. Kalantar-Zadeh K, Block G, Horwich T, et al: Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004; 43: 1439-1444. (Pubitemid 38496352)
8. Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.6 (Updated March 2012). The Cochrane Collaboration, 2012. www.cochrane-handbook.org.
9. Hoogeveen EK, Halbesma N, Rothman KJ, et al: Obesity and mortality risk among younger dialysis patients. Clin J Am Soc Nephrol 2012; 7: 1-9.
10. Leavey SF, McCullough K, Hecking E, et al: Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2001; 16: 2384-2394.
11. Beddhu S, Pappas LM, Ramkumar N, Samore M: Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003; 14: 2366-2372. (Pubitemid 37069205)
12. Kalantar-Zadeh K, Streja E, Kovesdy CP, et al: The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc 2010; 85: 991-1001.
13. Ricks J, Molnar MZ, Kovesdy CP, et al: Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients. Am J Kidney Dis 2011; 58: 574-582.
14. Johansen KL, Young B, Kaysen GA, et al: Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 2004; 80: 324-332. (Pubitemid 41080005)
15. Kalantar-Zadeh K, Kilpartrick RD, Kuwae N, et al: Reverse epidemiology: a spurious hypothesis or a hardcore reality Blood Purif 2005; 23: 57-63. (Pubitemid 40082245)
16. Ness A, Gunnell D, Hughes J, et al: Height, body mass index, and survival in men with coronary disease: follow up of the Diet and Reinfarction Trial (DART). J Epidemiol Community Health 2002; 56: 218-219. (Pubitemid 34174447)
17. Antigone O, Raj P, Kalantar-Zadeh K, et al: Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008; 156: 13-22. (Pubitemid 351862293)
18. Ghali JK, Tam SW, Ferdinand KC, et al: Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial. Am J Cardiovasc Drugs 2007; 7: 373-380. (Pubitemid 47624541)
19. Eqorova EN, Kalinkin MN, Mazur ES: Endotoxinemia and systemic inflammation in pathogenesis of chronic heart failure. Patol Fiziol Eksp Ter 2011; 4: 42-46.
20. Kalantar-Zadeh K, Kopple JD, Humphreys MH, et al: Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1507-1519. (Pubitemid 38796421)
21. Kalantar-Zadeh K, Kamranpour N, Kopple JD: Association between novel HDL inflammation/anti-inflammation properties with body mass index in hemodialysis patients. J Am Soc Nephrol 2004; 15(suppl):172A.
22. Fitzqibbons TP, Hardy OT, Lessard D, et al: Body mass index, treatment practices, and mortality in patients with acute heart failure. Coron Artery Dis 2009; 20: 536-543.
23. Agarwal R: Body mass index-mortality paradox in hemodialysis: can it be explained by blood pressure Hypertension 2011; 58: 1014-1020.
24. Eqan M, Tannahill C, Petticrew M, et al: Psychosocial risk factors in home and community settings and their associations with population health and health inequalities: a systematic meta-review. BMC Public Health 2008; 8: 239.
25. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91. (Pubitemid 23036092)
26. Atlantis E, Martin SA, Haren MT, et al: Inverse associations between muscle mass, strength, and the metabolic syndrome. Metabolism 2009; 58: 1013-1022.
27. Ikizler TA, Wingard RL, Harvell J, et al: Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int 1999; 55: 1945-1951. (Pubitemid 29197983)
28. Honda H, Qureshi AR, Axelsson J, et al: Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 2007; 86: 633-638. (Pubitemid 47435829)
29. Huang CX, Tighiouart H, Beddhu S, et al: Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int 2010; 77: 624-629.
30. Gotch FA: Kt/V is the best dialysis dose parameter. Blood Purif 2000; 18: 276-285.
31. Horber FF, Kohler SA, Lippuner K, et al: Effect of regular physical training on age-associated alteration of body composition in men. Eur J Clin Invest 1996; 26: 279-285. (Pubitemid 26148593)
32. Mustata S, Chan C, Lai V, et al: Impact of an exercise program on arterial stiffness and insulin resistance in hemodialysis patients. J Am Soc Nephrol 2004; 15: 2713-2718. (Pubitemid 41103378)
33. Shoji T, Emoto M, Shinohara K, et al: Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 2001; 12: 2117-2124. (Pubitemid 32880348)
34. Shinohara K, Shoji T, Emoto M, et al: Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 1894-1900. (Pubitemid 34700615)
35. Cordeiro AC, Qureshi AR, Stenvinkel P, et al: Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant 2010; 25: 562-568.
36. Pischon T, Boeing H, Hoffmann K, et al: General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-2120.
37. Postorino M, Marino C, Tripepi G, et al: Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009; 53: 1265-1272.
38. Axelsson J, Rashid Qureshi A, Suliman ME, et al: Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004; 80: 1222-1229. (Pubitemid 41350682)
39. Gohda T, Gotoh H, Tanimoto M, et al: Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients. Hypertens Res 2008; 31: 83-88. (Pubitemid 351325619)
40. Odamaki M, Furuya R, Kinumura Y, et al: Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients. Nephron Clin Pract 2006; 102:c8-c13. (Pubitemid 43250927)
41. Ramos LF, Shintani A, Ikizler TA, et al: Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol 2008; 19: 593-599. (Pubitemid 351355403)
42. Fouque D, Kalantar-Zadeh K, Kopple J, et al: A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-398. (Pubitemid 351186278)